May 8, 2018 / 10:44 PM / 14 days ago

BRIEF-CymaBay Therapeutics Q1 Loss Per Share $0.32

May 8 (Reuters) - CymaBay Therapeutics Inc:

* CYMABAY REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q1 LOSS PER SHARE $0.32

* Q1 EARNINGS PER SHARE VIEW $-0.14 — THOMSON REUTERS I/B/E/S

* QTRLY LOSS PER SHARE $0.32

* CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES TOTALED $229.5 MILLION AT END OF Q1 OF 2018

* EXISTING CASH IS EXPECTED TO FUND CYMABAY’S CURRENT OPERATING PLAN INTO 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below